On ECHEMI
Home > Drugs > CSPC OUYI Pharmaceutical Co., Ltd.
CSPC OUYI Pharmaceutical Co., Ltd.
  • Founded in:

    2001-03-29
  • Country:

    China China
  • Address:

    No. 88, Yangzi Road, Shijiazhuang Economic and Technological Development Zone
  • Tax NO.:

    91130100601289268L
  • Registered Funds:

    298 million yuan
  • Website:

  • Email:

Related Drugs
Oyster calcium carbonate granules
The main ingredient is oyster calcium carbonate.
Name Description Content CAS NO. Registered Holders
Oyster calcium carbonate

Participates in bone formation and reconstruction of bone tissue after fracture, as well as muscle contraction, nerve transmission, coagulation mechanism and reduces capillary permeability, etc.

More

Participates in bone formation and reconstruction of bone tissue after fracture, as well as muscle contraction, nerve transmission, coagulation mechanism and reduces capillary permeability, etc.

0
Triple Calcium Chewable Tablets
This product is a compound preparation. Each tablet contains 0.05 g of calcium lactate, calcium gluconate, and calcium hydrogen phosphate (equivalent to a total calcium content of 22.6 mg). The excipients are:
Name Description Content CAS NO. Registered Holders
Calcium lactate

Participates in bone formation and reconstruction of bone tissue after fracture, as well as muscle contraction, nerve transmission, coagulation mechanism, and can reduce the permeability of capillaries, etc.

More

Participates in bone formation and reconstruction of bone tissue after fracture, as well as muscle contraction, nerve transmission, coagulation mechanism, and can reduce the permeability of capillaries, etc.

0.05g 814-80-2 10
CALCIUM GLUCONATE MONOHYDRATE

Participates in bone formation and reconstruction of bone tissue after fracture, as well as muscle contraction, nerve transmission, coagulation mechanism, and can reduce the permeability of capillaries, etc.

More

Participates in bone formation and reconstruction of bone tissue after fracture, as well as muscle contraction, nerve transmission, coagulation mechanism, and can reduce the permeability of capillaries, etc.

0.05g 66905-23-5 35
Calcium phosphate dibasic

Participates in bone formation and reconstruction of bone tissue after fracture, as well as muscle contraction, nerve transmission, coagulation mechanism, and can reduce the permeability of capillaries, etc.

More

Participates in bone formation and reconstruction of bone tissue after fracture, as well as muscle contraction, nerve transmission, coagulation mechanism, and can reduce the permeability of capillaries, etc.

0.05g 7757-93-9 16
Metoprolol Tartrate Injection
1-Isopropylamino-3-[p-(2-methoxyethyl)phenoxy]-2-propanol L()-tartrate
Name Description Content CAS NO. Registered Holders
Metoprolol tartrate

Metoprolol is a selective beta-1 blocker, which means that lower doses are required to affect beta-1 receptors in the heart than to affect beta-2 receptors in peripheral vascular and bronchial sites. However, as the dose of metoprolol increases, its selectivity for beta-1 receptors decreases.

More

Metoprolol is a selective beta-1 blocker, which means that lower doses are required to affect beta-1 receptors in the heart than to affect beta-2 receptors in peripheral vascular and bronchial sites. However, as the dose of metoprolol increases, its selectivity for beta-1 receptors decreases.

56392-17-7 51
Vitamin B6 Injection
The main ingredient of this product is vitamin B6. Its chemical name is 6-methyl-5-hydroxy-3,4-pyridine dimethanol hydrochloride.
Name Description Content CAS NO. Registered Holders
Vitamin B6

Vitamin B6 is converted into pyridoxal phosphate in red blood cells and acts as a coenzyme in various metabolic functions of proteins, carbohydrates, and lipids. It is also involved in the conversion of tryptophan into niacin or 5-hydroxytryptamine.

More

Vitamin B6 is converted into pyridoxal phosphate in red blood cells and acts as a coenzyme in various metabolic functions of proteins, carbohydrates, and lipids. It is also involved in the conversion of tryptophan into niacin or 5-hydroxytryptamine.

8059-24-3 13
Chloramphenicol Injection
The main ingredient of this product is chloramphenicol, and its chemical name is D-threo-(-)-N-[α-(hydroxymethyl)-β-hydroxy-p-nitrophenylethyl]-2,2-dichloroacetamide.
Name Description Content CAS NO. Registered Holders
Chloramphenicol

This product has a broad-spectrum antimicrobial effect in vitro, including aerobic Gram-negative and Gram-positive bacteria, anaerobes, Rickettsia, spirochetes and Chlamydia. It has bactericidal effects on the following bacteria: influenza bacillus, Streptococcus pneumoniae and Neisseria meningitidis. It only has antibacterial effects on the following bacteria: Staphylococcus aureus, Streptococcus pyogenes, Streptococcus viridans, group B hemolytic Streptococcus, Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis, Salmonella typhi, Salmonella paratyphi, Shigella, Bacteroides fragilis and other anaerobic bacteria. The following bacteria are usually resistant to chloramphenicol: Pseudomonas aeruginosa, Acinetobacter, Enterobacter, Serratia marcescens, indole-positive Proteus, methicillin-resistant Staphylococcus and Enterococcus. This product is an antibacterial agent. Chloramphenicol is fat-soluble and enters bacterial cells by diffusion, and reversibly binds to the 50S subunit of the bacterial ribosome, which blocks the growth of the peptide chain (possibly due to the inhibition of the action of transpeptidase), thereby inhibiting the formation of peptide chains and preventing protein synthesis.

More

This product has a broad-spectrum antimicrobial effect in vitro, including aerobic Gram-negative and Gram-positive bacteria, anaerobes, Rickettsia, spirochetes and Chlamydia. It has bactericidal effects on the following bacteria: influenza bacillus, Streptococcus pneumoniae and Neisseria meningitidis. It only has antibacterial effects on the following bacteria: Staphylococcus aureus, Streptococcus pyogenes, Streptococcus viridans, group B hemolytic Streptococcus, Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis, Salmonella typhi, Salmonella paratyphi, Shigella, Bacteroides fragilis and other anaerobic bacteria. The following bacteria are usually resistant to chloramphenicol: Pseudomonas aeruginosa, Acinetobacter, Enterobacter, Serratia marcescens, indole-positive Proteus, methicillin-resistant Staphylococcus and Enterococcus. This product is an antibacterial agent. Chloramphenicol is fat-soluble and enters bacterial cells by diffusion, and reversibly binds to the 50S subunit of the bacterial ribosome, which blocks the growth of the peptide chain (possibly due to the inhibition of the action of transpeptidase), thereby inhibiting the formation of peptide chains and preventing protein synthesis.

56-75-7 14
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.